EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Synthesis, Anticancer Screening, and Virtual Analysis of 5-S-Substituted Derivatives of 1,3-Oxazol-4-ylphosphonates and 1,3-Oxazole-4-carbonitriles

Maryna V. Kachaeva, Oksana S. Bahrieieva, Oleksandr L. Kobzar, Yurii V. Shulga, Oleksandr V. Golovchenko, Oksana I. Golovchenko, Iryna V. Nizhenkovska, Oleksandr V. Mykhailenko, Stepan G. Pilyo, Victor V. Zhirnov, Volodymyr S. Brovarets

SynOpen · 01.12.2025 · 09 (04) · 268-281

DOI: 10.1055/a-2741-9575 ↗

Kurz gefasst

Fachartikel in der Zeitschrift SynOpen, erschienen am 01.12.2025. Verfasst von Maryna V. Kachaeva und 10 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Academy of Sciences of Ukraine.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ten 5-(arylsulfanyl), 5-(arylsulfinyl), and 5-(arylsulfonyl) derivatives of 1,3-oxazol-4-ylphosphonates and 1,3-oxazole-4-carbonitriles were synthesized and characterized using IR, 1H NMR, 13C NMR, 31P NMR spectroscopy, elemental analysis, and mass spectrometry. Their anticancer activity was assessed against NCI-60 human tumor cell lines using a single-dose assay. Diethyl [2-phenyl-5-(phenylsulfonyl)-1,3-oxazol-4-yl]phosphonate, diethyl [5-(4-chlorophenylsulfonyl)-2-(4-methylphenyl)-1,3-oxazol-4-yl]phosphonate, and 5-(4-methylphenylsulfonyl)-2-phenyl-1,3-oxazole-4-carbonitrile, which demonstrated the highest anticancer activity, were selected for five-dose screening. The two phosphonates showed selectivity (SIr > 3 by TGI and LC50) against most leukemia lines, while the 1,3-oxazole-4-carbonitrile derivative was selective against renal (63%), colon (57%), and breast cancer (50%). One compound demonstrated selectivity against the entire leukemia subpanel. A comparison analysis revealed that no standard drug exhibited a high degree of similarity to compounds across all potency vectors. This suggests that the molecular mechanisms may be unique. Possible targets such as cannabinoid receptor 2, adenosine A3 receptor, and cyclin-dependent kinase 2 have been proposed based on in silico studies. The parameters of druglikeness predicted by the ADMET analysis were within the rational range for all compounds. The two phosphonates are expected to be preferable for the development of antileukemia agents, while 5-(4-methylphenylsulfonyl)-2-phenyl-1,3-oxazole-4-carbonitrile is considered promising for agents targeting renal, colon, and breast cancers.

Förderung

  • National Academy of Sciences of Ukraine

Zitieren

APA

Kachaeva, M. V., Bahrieieva, O. S., Kobzar, O. L., Shulga, Y. V., Golovchenko, O. V., Golovchenko, O. I., Nizhenkovska, I. V., Mykhailenko, O. V., Pilyo, S. G., Zhirnov, V. V., & Brovarets, V. S. (2025). Synthesis, Anticancer Screening, and Virtual Analysis of 5-S-Substituted Derivatives of 1,3-Oxazol-4-ylphosphonates and 1,3-Oxazole-4-carbonitriles. SynOpen, 09(04), 268-281. https://doi.org/10.1055/a-2741-9575

Vancouver

Kachaeva MV, Bahrieieva OS, Kobzar OL, Shulga YV, Golovchenko OV, Golovchenko OI, et al. Synthesis, Anticancer Screening, and Virtual Analysis of 5-S-Substituted Derivatives of 1,3-Oxazol-4-ylphosphonates and 1,3-Oxazole-4-carbonitriles. SynOpen. 2025;09(04):268-281. doi:10.1055/a-2741-9575

BibTeX
@article{Kachaeva2025,
  author = {Kachaeva, Maryna V. and Bahrieieva, Oksana S. and Kobzar, Oleksandr L. and Shulga, Yurii V. and Golovchenko, Oleksandr V. and Golovchenko, Oksana I. and Nizhenkovska, Iryna V. and Mykhailenko, Oleksandr V. and Pilyo, Stepan G. and Zhirnov, Victor V. and Brovarets, Volodymyr S.},
  title = {Synthesis, Anticancer Screening, and Virtual Analysis of 5-S-Substituted Derivatives of 1,3-Oxazol-4-ylphosphonates and 1,3-Oxazole-4-carbonitriles},
  journal = {SynOpen},
  year = {2025},
  volume = {09},
  number = {04},
  pages = {268--281},
  doi = {10.1055/a-2741-9575}
}
Kostenlos starten →